However, no inequalities on how the reform affected the risk of insulin initiation were found between income quintiles, implying co-payments unlikely are the most influential factor behind persisting inequalities in insulin initiation among individuals with type 2 diabetes in Finland. This evidence concerns the gene INS and type 2 diabetes mellitus.